A multi-institutional experience in pediatric high-grade glioma

Frontiers in Oncology

Volumn 5, Issue FEB, 2015, Pages

  Walston, Steve ^a   Hamstra, Daniel A ^b   Oh, Kevin ^c   Woods, Gary ^d   Guiou, Michael ^a   Olshefski, Randal S ^d   Chakravarti, Arnab ^a   Williams, Terence M ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

Chemotherapy; Glioblastoma; High grade glioma; Pediatric cancer; Radiation therapy

Indexed keywords

LOMUSTINE; PREDNISONE; PROCARBAZINE; TEMOZOLOMIDE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; BIOPSY; CANCER PROGNOSIS; CANCER STAGING; CHEMORADIOTHERAPY; CHILD; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; GLIOMA; HUMAN; HUMAN TISSUE; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; PROPORTIONAL HAZARDS MODEL; RADIATION DOSE; RETROSPECTIVE STUDY; SEIZURE; SURVIVAL RATE; TUMOR VOLUME; UNIVARIATE ANALYSIS;

EID: 84923227139     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2015.00028     Document Type: Article

References (16)

1. Dolecek TA, Propp JM, Stroup NE, Kruchko C. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. Neuro Oncol (2012) 14(Suppl 5):v1-49. doi: 10.1093/neuonc/nos218
2. Fangusaro J. Pediatric high grade glioma: a review and update on tumor clinical characteristics and biology. Front Oncol (2012) 2:105. doi:10.3389/fonc.2012.00105
3. Broniscer A, Gajjar A. Supratentorial high-grade astrocytoma and diffuse brainstem glioma: two challenges for the pediatric oncologist. Oncologist (2004) 9:197-206. doi:10.1634/theoncologist.9-2-197
4. Fangusaro J, Warren KE. Unclear standard of care for pediatric high grade glioma patients. J Neurooncol (2013) 113:341-2. doi:10.1007/s11060-013-1104-8
5. Sposto R, Ertel IJ, Jenkin RD, Boesel CP, Venes JL, Ortega JA, et al. The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. A report from the Children's Cancer Study Group. J Neurooncol (1989) 7:165-77. doi:10.1007/BF00165101
6. Finlay JL, Boyett JM, Yates AJ, Wisoff JH, Milstein JM, Geyer JR, et al. Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Children's Cancer Group. J Clin Oncol (1995) 13:112-23.
7. Perkins SM, Rubin JB, Leonard JR, Smyth MD, El Naqa I, Michalski JM, et al. Glioblastoma in children: a single-institution experience. Int J Radiat Oncol Biol Phys (2011) 80:1117-21. doi:10.1016/j.ijrobp.2010.03.013
8. Vaidya SJ, Hargrave D, Saran F, Britton J, Soomal R, Bouffet E. Pattern of recurrence in paediatric malignant glioma: an institutional experience. J Neurooncol (2007) 83:279-84. doi:10.1007/s11060-006-9313-z
9. Stupp R, Mason WP, Van Den Bent MJ, Weller M, Fisher B, Taphoorn MJB, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med (2005) 352:987-96. doi:10.1056/NEJMoa043330
10. Jones C, Perryman L, Hargrave D. Paediatric and adult malignant glioma: close relatives or distant cousins? Nat Rev Clin Oncol (2012) 9:400-13. doi:10.1038/nrclinonc.2012.87
11. Song KS, Phi JH, Cho BK, Wang KC, Lee JY, Kim DG, et al. Long-term outcomes in children with glioblastoma. J Neurosurg Pediatr (2010) 6:145-9. doi:10.3171/2010.5.PEDS09558
12. Cohen KJ, Pollack IF, Zhou T, Buxton A, Holmes EJ, Burger PC, et al. Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group. Neuro Oncol (2011) 13:317-23. doi:10.1093/neuonc/noq191
13. Pollack IF, Hamilton RL, Sobol RW, Burnham J, Yates AJ, Holmes EJ, et al. O6-methylguanine-DNA methyltransferase expression strongly correlates with outcome in childhood malignant gliomas: results from the CCG-945 Cohort. J Clin Oncol (2006) 24:3431-7. doi:10.1200/JCO.2006.05.7265
14. Donson AM, Addo-Yobo SO, Handler MH, Gore L, Foreman NK. MGMT promoter methylation correlates with survival benefit and sensitivity to temozolomide in pediatric glioblastoma. Pediatr Blood Cancer (2007) 48:403-7. doi:10.1002/pbc.20803
15. Fallai C, Olmi P. Hyperfractionated and accelerated radiation therapy in central nervous system tumors (malignant gliomas, pediatric tumors, and brain metastases). Radiother Oncol (1997) 43:235-46. doi:10.1016/S0167-8140(96)01897-X
16. Pollack IF, Boyett JM, Yates AJ, Burger PC, Gilles FH, Davis RL, et al. The influence of central review on outcome associations in childhood malignant gliomas: results from the CCG-945 experience. Neuro Oncol (2003) 5:197-207. doi:10.1215/S1152851703000097